Modern advances in genetics now allow us to examine the entire chromosomal material of an embryo before it is transferred to the uterus. With Comprehensive Chromosome Screening (CCS) we can select embryos with normal chromosome numbers, increasing the chances of successful implantation and development of a healthy pregnancy.

Who is the test recommended for?

Although the technique does not necessarily apply to all couples, there are specific cases where it can offer significant benefits:

• Women over 35
  With increasing age, the likelihood of fetuses having chromosomal abnormalities also increases.
  Research shows that:

  • At ages 35–39, approximately 1 in 5 fetuses (20%) have chromosomal abnormalities.

  • After 40 years, this percentage exceeds 50%.
    These embryos often do not implant or may lead to miscarriage.

• Women with recurrent miscarriages (recurrent miscarriages)
  CCS can help identify healthy embryos that have an increased chance of developing into a pregnancy.

• When infertility is related to a serious male factor
  In cases of very low sperm quality, the likelihood of chromosomal abnormalities in the fetus increases.

• After multiple failed IVF attempts
  When embryos fail to implant, a chromosomal abnormality may be the cause. CCS helps select embryos with a higher chance of success.

Why it may be important

The CCS method doesn't just increase the chances of a positive chorionic villus sampling — it aims for a healthy, viable pregnancy. By selecting embryos with a normal karyotype, we reduce the risk of miscarriage and increase the likelihood of a pregnancy that progresses smoothly.